Navigation Links
Pernix Therapeutics Introduces Omeclamox-Pak®, First Product in Gastroenterology Portfolio
Date:5/15/2012

THE WOODLANDS, Texas, May 15, 2012 /PRNewswire/ -- Pernix Therapeutics Holdings, Inc. (NYSE Amex: PTX), a specialty pharmaceutical company, today announced the introduction of Omeclamox-Pak®, a ten-day therapy of omeprazole delayed-release capsules (20 mg), clarithromycin tablets (500 mg) and amoxicillin capsules (500 mg) for the treatment of Helicobacter pylori (H. pylori) infection and duodenal ulcer disease (active or one-year history) to eradicate H. pylori in adult patients.   

Cooper Collins, President and Chief Executive Officer of Pernix Therapeutics, said, "The introduction of Omeclamox-Pak is an important milestone for Pernix as the company's prescription portfolio continues to broaden with the addition of a new branded product that will be launched by our newly established gastroenterology sales force. We are pleased to offer patients suffering from H. pylori infection and duodenal ulcers with a new treatment option that we expect will be available by prescription in July 2012."

Omeclamox-Pak® is a triple combination medication taken orally to treat Helicobacter pylori infection and eradicate duodenal ulcer disease in adults. Treatment consists of the protein pump inhibitor omeprazole and two broad spectrum antibiotics; clarithromycin tablets and amoxicillin capsules. The medications are to be taken together, twice daily, for ten days. 

"We have recruited a new sales force and established a targeted marketing program that will reach gastroenterology professionals in the coming months," said Chuck Hrushka, Vice President of Sales and Marketing at Pernix Therapeutics. "We anticipate physicians and their patients will welcome the short, 10-day dosing regimen, especially when compared to other treatments."

About Omeclamox-Pak®
Omeprazole is an antisecretory drug, wh
'/>"/>

SOURCE Pernix Therapeutics Holdings, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Particle Sciences and Pernix Therapeutics Enter into an Agreement to Develop a Pediatric Dermatology Product
2. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
3. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
4. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
5. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
6. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
7. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
8. Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
9. TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel
10. TorreyPines Therapeutics Completes Phase I Multiple Dose Clinical Trial of NGX267, a Selective M1 Agonist for the Potential Treatment of Cognitive Impairment Associated with Schizophrenia
11. Cell Therapeutics, Inc. (CTI) Launches Phase III Study for Pixantrone in Relapsed Indolent Non-Hodgkins Lymphoma (NHL)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... -- Royal Philips (NYSE: PHG, AEX: PHIA) ... in Imaging Equipment in the 2013 Best in KLAS ... Best in KLAS and Best in Category awards for ... Computed Tomography (CT), Ingenia 1.5T and 3.0T Magnetic Resonance ... Best in KLAS Awards: Medical Imaging & Infrastructure are ...
(Date:6/18/2013)... June 18, 2013  Specialty Coating Systems ... in Parylene coating technologies: SCS microRESIST™ Antimicrobial ... of Parylene with antimicrobial properties to effectively ... components. (Logo: http://photos.prnewswire.com/prnh/20130618/DE33772LOGO ... increase and continue to pose a challenge ...
(Date:6/18/2013)... BURLINGTON, Mass. , June 18, 2013 Decision ... for pharmaceutical and healthcare issues, finds that, over the past ... ( France , Germany , ... and the United Kingdom ) have been ... most of their HIV patients, primarily to reduce costs. Additionally, ...
Breaking Medicine Technology:Philips Named 2013 Overall Performance Leader In Imaging Equipment By KLAS 2Specialty Coating Systems Announces New Antimicrobial Parylene Technology 2One in Four Surveyed EU5 Physicians Has Been Required to Change a Prescription for Some or Most of Their HIV Patients in the Past Twelve Months, Primarily to Reduce Costs 2One in Four Surveyed EU5 Physicians Has Been Required to Change a Prescription for Some or Most of Their HIV Patients in the Past Twelve Months, Primarily to Reduce Costs 3
... Extension, a global authority on nutrition, health, and wellness ... product featuring ChromaDex,s (CDXC.OB) pTeroPure pterostilbene, which is now ... retailers. Life Extension pTeroPure contains 50 mg ...  Pterostilbene has been shown to be superior ...
... 6, 2011 Alere Health, LLC announced today ... Quality Assurance (NCQA) Health Information Products Certification for ... Nurse24(SM) program − a 24/7 nurseline staffed by ... make smarter healthcare decisions by providing immediate clinical ...
Cached Medicine Technology:Life Extension® Launches New Product Containing ChromaDex's pTeroPure® Pterostilbene 2Life Extension® Launches New Product Containing ChromaDex's pTeroPure® Pterostilbene 3Alere Earns NCQA Health Information Products Certification for Health Information Line 2
(Date:6/18/2013)... 2013 Palo Alto has taken yet another ... cities with its recent major long-term solar power commitment. ... solar electric power purchase agreements , which together will result ... solar photovoltaic electric power per year, which is the equivalent ... That’s enough power to supply all 65,000+ Palo Alto residents---and ...
(Date:6/18/2013)... Recent research has shown that cancer cells have a ... normal cells. Now, scientists at The University of Texas ... provide a new strategy to combat lung cancer. , ... journal PLOS ONE , UT Dallas researchers compared ... normal lung cells taken from the same patient. ...
(Date:6/18/2013)... (PRWEB) June 18, 2013 The July 2013 ... Cheater’s Guide to Getting Beach Ready,” offers a list of ... look their best in a bathing suit this summer. The ... skin firming , smoothing cellulite , and more. (go ... Ourian, Medical Director of Epione Beverly Hills, “though I would ...
(Date:6/18/2013)... FL (PRWEB) June 18, 2013 A ... by storm. The burgeoning aquaculture industry is redefining the ... one of the most acclaimed personal culinary chefs on ... clientele on benefits of sustainable seafood and the promising ... in abundance these days. Many consumers strive to fully ...
(Date:6/18/2013)... one of the most successful Facebook brands of all time ... article What We Can Learn From one of the ... brand Gollan refers to is the multi-national Coca Cola who, ... (and rising). , The brand featured at number ten ... The Facebook data tracking publication ranked the brand highly because ...
Breaking Medicine News(10 mins):Health News:Palo Alto Seals the Deal on Major Solar Electric Investments 2Health News:Palo Alto Seals the Deal on Major Solar Electric Investments 3Health News:UT Dallas study suggests new approach to fight lung cancer 2Health News:UT Dallas study suggests new approach to fight lung cancer 3Health News:Skin Care – Getting Your Body Beach Ready 2Health News:New $119 Million Industry Swimming Up the East Coast 2Health News:Casey Gollan Shows What We Can Learn From One of the Best Facebook Pages There Is 2Health News:Casey Gollan Shows What We Can Learn From One of the Best Facebook Pages There Is 3
... with increasingly hectic work, school and extracurricular schedules, the ... time between parents and children. University of Missouri human ... vital step in maintaining family relationships and health. ... Environmental Sciences, says that instead of watching TV or ...
... , TUESDAY, Oct. 11 (HealthDay News) -- Studies on the ... plagued by design problems, a new report issued by the ... evidence exists that this kind of therapy helps such patients ... to develop definitive guidelines for its use. With traumatic ...
... , TUESDAY, Oct. 11 (HealthDay News) -- A healthy diet ... effect of a gene associated with an increased risk of ... published in the current online edition of the journal ... gene variant and diet in more than 27,000 people of ...
... By Randy Dotinga HealthDay Reporter , TUESDAY, Oct. 11 ... supplements seem to reduce inflammation in the intestines -- a potential ... However, more study needs to be done, and the ... or start gobbling up more ginger at meal times. "If ...
... (Oct. 11, 2011) According to new research by ... in treating a variety of diseases may produce unintended ... RNAs Induce Retinal Degeneration via TLR3 and IRF3", appears ... Molecular Therapy, a publication of the Nature Publishing ...
... Center is exploring the ethical challenges that clinicians ... immigrants in the United States. The project is supported ... Rights Program. Most of the estimated 11 million ... and are ineligible for public insurance programs. They are ...
Cached Medicine News:Health News:Human development experts recommend tuning in to family, not devices 2Health News:Evidence Lacking That Cognitive Rehab Therapy Helps Brain-Injured Vets 2Health News:Evidence Lacking That Cognitive Rehab Therapy Helps Brain-Injured Vets 3Health News:Healthy Diet May Counteract Heart Disease Gene 2Health News:Ginger Supplements Might Ease Inflammation Linked to Colon Cancer 2Health News:Emerging pharmaceutical platform may pose risks to retinal health 2Health News:New project examines medical safety net for undocumented patients 2
... designed specifically for the Palm Organizers ... ward rounds. It is intended to ... consultations that are requested by the ... Ward round examinations and to record ...
... tracking and billing. This ... Handheld application, a complete ... CPT™ and ICD-9-CM codes ... Designed for any medical ...
In addition to the patient data OB-on-Call contains a comprehensive Medications list displaying related drugs by brand name, generic title, and usage description notes....
Archimedes is an innovative specialty calculator. Forget having to remember complicated formulas, just enter the values and out come the results....
Medicine Products: